Kosma VM - Search Results

1

Expression of CD 44 s, CD 44 v 3 and CD 44 v 6 in benign and malignant breast lesions: correlation and colocalization with hyaluronan.

Auvinen P, Tammi R, Tammi M, Johansson R, Kosma VM. Auvinen P, et al. Among authors: kosma vm. Histopathology. 2005 Oct;47(4):420-8. doi: 10.1111/j.1365-2559.2005.02220.x. Histopathology. 2005. PMID: 16178897

2

Versican expression in pharyngeal squamous cell carcinoma: an immunohistochemical study.

Pukkila MJ, Kosunen AS, Virtaniemi JA, Kumpulainen EJ, Johansson RT, Kellokoski JK, Nuutinen J, Kosma VM. Pukkila MJ, et al. Among authors: kosma vm. J Clin Pathol. 2004 Jul;57(7):735-9. doi: 10.1136/jcp.2003.014589. J Clin Pathol. 2004. PMID: 15220367 Free PMC article.

3

Reduced expression of hyaluronan is a strong indicator of poor survival in oral squamous cell carcinoma.

Kosunen A, Ropponen K, Kellokoski J, Pukkila M, Virtaniemi J, Valtonen H, Kumpulainen E, Johansson R, Tammi R, Tammi M, Nuutinen J, Kosma VM. Kosunen A, et al. Among authors: kosma vm. Oral Oncol. 2004 Mar;40(3):257-63. doi: 10.1016/j.oraloncology.2003.08.004. Oral Oncol. 2004. PMID: 14747056

4

Hyaluronan in human malignancies.

Sironen RK, Tammi M, Tammi R, Auvinen PK, Anttila M, Kosma VM. Sironen RK, et al. Among authors: kosma vm. Exp Cell Res. 2011 Feb 15;317(4):383-91. doi: 10.1016/j.yexcr.2010.11.017. Epub 2010 Dec 3. Exp Cell Res. 2011. PMID: 21134368 Review.

5

Depletion of cell surface CD44 in nonmelanoma skin tumours is associated with increased expression of matrix metalloproteinase 7.

Hartmann-Petersen S, Tammi RH, Tammi MI, Kosma VM. Hartmann-Petersen S, et al. Among authors: kosma vm. Br J Dermatol. 2009 Jun;160(6):1251-7. doi: 10.1111/j.1365-2133.2009.09031.x. Epub 2009 Feb 16. Br J Dermatol. 2009. PMID: 19222463

6

CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma.

Kosunen A, Pirinen R, Ropponen K, Pukkila M, Kellokoski J, Virtaniemi J, Sironen R, Juhola M, Kumpulainen E, Johansson R, Nuutinen J, Kosma VM. Kosunen A, et al. Among authors: kosma vm. Oral Oncol. 2007 Jan;43(1):51-9. doi: 10.1016/j.oraloncology.2006.01.003. Epub 2006 Jun 23. Oral Oncol. 2007. PMID: 16798062

7

Biological and prognostic role of acid cysteine proteinase inhibitor (ACPI, cystatin A) in non-small-cell lung cancer.

Leinonen T, Pirinen R, Böhm J, Johansson R, Rinne A, Weber E, Kosma VM. Leinonen T, et al. Among authors: kosma vm. J Clin Pathol. 2007 May;60(5):515-9. doi: 10.1136/jcp.2006.038711. Epub 2006 Jun 21. J Clin Pathol. 2007. PMID: 16790691 Free PMC article.

8

Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer.

Voutilainen KA, Anttila MA, Sillanpää SM, Ropponen KM, Saarikoski SV, Juhola MT, Kosma VM. Voutilainen KA, et al. Among authors: kosma vm. J Clin Pathol. 2006 May;59(5):460-7. doi: 10.1136/jcp.2005.029876. Epub 2006 Feb 3. J Clin Pathol. 2006. PMID: 16461565 Free PMC article.

9

Expression of HER2 and its association with AP-2 in breast cancer.

Pellikainen J, Naukkarinen A, Ropponen K, Rummukainen J, Kataja V, Kellokoski J, Eskelinen M, Kosma VM. Pellikainen J, et al. Among authors: kosma vm. Eur J Cancer. 2004 Jul;40(10):1485-95. doi: 10.1016/j.ejca.2004.02.020. Eur J Cancer. 2004. PMID: 15196531

10

p21WAF1 expression in invasive breast cancer and its association with p53, AP-2, cell proliferation, and prognosis.

Pellikainen MJ, Pekola TT, Ropponen KM, Kataja VV, Kellokoski JK, Eskelinen MJ, Kosma VM. Pellikainen MJ, et al. Among authors: kosma vm. J Clin Pathol. 2003 Mar;56(3):214-20. doi: 10.1136/jcp.56.3.214. J Clin Pathol. 2003. PMID: 12610102 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results